A new film about leukemia drugs opened in Chinese theaters last week, and it’s already become a blockbuster hit. The movie, called “Dying to Survive,” brought in $232 million in its first five days, a pace that gives it a chance to become China’s biggest-ever box-office success.

The dark comedy centers around a Chinese man who illegally smuggles cheap generic leukemia drugs from India to sell to Chinese patients who can’t afford the medication available through official channels — a pricey drug called Glinic sold by a greedy Swiss pharma company. Sound familiar?

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy